Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafari, Anya, Dadkhahfar, Sahar, Perseh, Sahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217119/
https://www.ncbi.nlm.nih.gov/pubmed/32460133
http://dx.doi.org/10.1016/j.critrevonc.2020.102982
_version_ 1783532552082948096
author Jafari, Anya
Dadkhahfar, Sahar
Perseh, Sahra
author_facet Jafari, Anya
Dadkhahfar, Sahar
Perseh, Sahra
author_sort Jafari, Anya
collection PubMed
description SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents.
format Online
Article
Text
id pubmed-7217119
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72171192020-05-12 Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments Jafari, Anya Dadkhahfar, Sahar Perseh, Sahra Crit Rev Oncol Hematol Article SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents. Elsevier B.V. 2020-07 2020-05-12 /pmc/articles/PMC7217119/ /pubmed/32460133 http://dx.doi.org/10.1016/j.critrevonc.2020.102982 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jafari, Anya
Dadkhahfar, Sahar
Perseh, Sahra
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
title Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
title_full Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
title_fullStr Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
title_full_unstemmed Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
title_short Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
title_sort considerations for interactions of drugs used for the treatment of covid-19 with anti-cancer treatments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217119/
https://www.ncbi.nlm.nih.gov/pubmed/32460133
http://dx.doi.org/10.1016/j.critrevonc.2020.102982
work_keys_str_mv AT jafarianya considerationsforinteractionsofdrugsusedforthetreatmentofcovid19withanticancertreatments
AT dadkhahfarsahar considerationsforinteractionsofdrugsusedforthetreatmentofcovid19withanticancertreatments
AT persehsahra considerationsforinteractionsofdrugsusedforthetreatmentofcovid19withanticancertreatments

Ejemplares similares